14/03/2026
THE IMPLICATION OF REVISED SCHEDULE M & BENEFITS FOR FRANCHISE MARKETING
The enforcement of revised Schedule M elevates India’s pharmaceutical manufacturing to WHO-aligned GMP standards, emphasizing quality risk management, data integrity, validated systems, and contamination controls. This reduces product recalls, contamination risks, and regulatory penalties, minimizing supply disruptions and enhancing overall industry credibility.
For marketing professionals working as franchisees, these norms provide stronger credibility to promote products as high-quality and safe, building greater trust with doctors, pharmacies, and patients. Franchisees gain competitive advantages, such as easier market pe*******on, potential premium pricing, and access to export-oriented principals, boosting sales volumes and margins.
Additionally, compliance signals reliability to regulators and investors, opening doors for franchise expansions into institutional sales or international markets where GMP certification is mandatory.
Regards,
JAKSTAR PHARMA
